FIELD: pharmaceuticals.
SUBSTANCE: invention relates to the pharmaceutical industry, namely to a combination for pharmacorrection of cognitive dysfunctions after ketamine anesthesia. The combination for pharmacorrection of cognitive dysfunctions after ketamine anesthesia consists of thiotriazoline and gamma-aminobutyric acid, where thiotriazoline and gamma-aminobutyric acid are in a certain ratio.
EFFECT: combination shows expressed nootropic and anti-amnestic effects, increasing the overall activity during learning and reducing the number of errors in reference and working memory when reproducing learning skills, which indicates a high pharmacological effect of the combination in the pharmacorrection of cognitive dysfunctions after ketamine anesthesia.
1 cl, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINED DRUG OF ANXIOLITHIC, STRESS-PROTECTOR, NOOTROPIC AND ANTIOXIDANT ACTION | 2016 |
|
RU2625754C1 |
| AGENT POSSESSING NEUROPROTECTIVE ACTION IN ISCHEMIC CEREBRAL CIRCULATION DISORDER | 2015 |
|
RU2586301C1 |
| COMBINED DRUG FOR PRIMARY NEUROPROTECTION | 2017 |
|
RU2636616C1 |
| AGENT POSSESSING CEREBRAL-PROTECTIVE, ENDOTHELIAL-POSITIVE AND ANTITHROMBOTIC EFFECT | 2015 |
|
RU2594254C1 |
| MEDICINE COMPOSITION, POSSESSING NOOTROPIC ACTIVITY | 2007 |
|
RU2331432C1 |
| METHOD OF TREATING PATIENTS WITH CHRONIC ALCOHOL INTOXICATION | 2014 |
|
RU2566075C1 |
| NEUROTROPIC DRUG AND METHOD FOR ITS PRODUCTION | 2007 |
|
RU2359962C1 |
| MEDICINAL AGENT SHOWING MULTIFACTOR NEUROPROTECTIVE AND NOOTROPIC EFFECT IN CRANIAL TRAUMA | 2005 |
|
RU2318501C2 |
| MEANS FOR CORRECTION OF CHOLINERGIC DISORDERS OF THE MNESTIC PROCESSES | 2017 |
|
RU2665970C1 |
| CEREBRAL PROTECTIVE AND STRESS-PROTECTIVE MEDICINAL AGENT "NOOTRIL" AS INJECTION SOLUTION | 2003 |
|
RU2268711C2 |
